JP2007536245A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536245A5 JP2007536245A5 JP2007511502A JP2007511502A JP2007536245A5 JP 2007536245 A5 JP2007536245 A5 JP 2007536245A5 JP 2007511502 A JP2007511502 A JP 2007511502A JP 2007511502 A JP2007511502 A JP 2007511502A JP 2007536245 A5 JP2007536245 A5 JP 2007536245A5
- Authority
- JP
- Japan
- Prior art keywords
- atazanavir
- total
- time
- sulfuric acid
- bisulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YTDMTTYOLYTDMS-LLVKDONJSA-N CC(C)(C)[C@@H](C(O[n]1nnc2ccccc12)=O)NC(OC)=O Chemical compound CC(C)(C)[C@@H](C(O[n]1nnc2ccccc12)=O)NC(OC)=O YTDMTTYOLYTDMS-LLVKDONJSA-N 0.000 description 1
- OKXLMWIFNMTTDR-PSWJWLENSA-N CCC(C)(CC)[C@@H](C(N[C@@H](Cc1ccccc1)[C@H](CN(Cc(cc1)ccc1-c1ccccn1)NC([C@H](C(C)(C)C)NC(OC)=O)=O)O)=O)NC(OC)=O Chemical compound CCC(C)(CC)[C@@H](C(N[C@@H](Cc1ccccc1)[C@H](CN(Cc(cc1)ccc1-c1ccccn1)NC([C@H](C(C)(C)C)NC(OC)=O)=O)O)=O)NC(OC)=O OKXLMWIFNMTTDR-PSWJWLENSA-N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56804304P | 2004-05-04 | 2004-05-04 | |
| US60/568,043 | 2004-05-04 | ||
| US60753304P | 2004-09-07 | 2004-09-07 | |
| US60/607,533 | 2004-09-07 | ||
| US11/119,558 | 2005-05-02 | ||
| US11/119,558 US7829720B2 (en) | 2004-05-04 | 2005-05-02 | Process for preparing atazanavir bisulfate and novel forms |
| PCT/US2005/015333 WO2005108349A2 (en) | 2004-05-04 | 2005-05-03 | Process for preparing atazanavir bisulfate and novel forms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007536245A JP2007536245A (ja) | 2007-12-13 |
| JP2007536245A5 true JP2007536245A5 (https=) | 2009-10-22 |
| JP5086069B2 JP5086069B2 (ja) | 2012-11-28 |
Family
ID=35310244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007511502A Expired - Lifetime JP5086069B2 (ja) | 2004-05-04 | 2005-05-03 | 重硫酸アタザナビルおよび新規形態の製造方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US7829720B2 (https=) |
| EP (3) | EP1755596B9 (https=) |
| JP (1) | JP5086069B2 (https=) |
| KR (1) | KR101153606B1 (https=) |
| AU (2) | AU2005240622B2 (https=) |
| BR (1) | BRPI0509595B8 (https=) |
| CA (2) | CA2777216A1 (https=) |
| CY (1) | CY1116919T1 (https=) |
| DK (1) | DK1755596T5 (https=) |
| ES (1) | ES2552219T3 (https=) |
| HR (1) | HRP20150962T2 (https=) |
| HU (1) | HUE026242T2 (https=) |
| IL (1) | IL178965A (https=) |
| MX (1) | MXPA06012612A (https=) |
| NO (1) | NO341013B1 (https=) |
| PL (1) | PL1755596T3 (https=) |
| PT (1) | PT1755596E (https=) |
| RS (1) | RS54284B1 (https=) |
| SI (1) | SI1755596T1 (https=) |
| WO (1) | WO2005108349A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200534879A (en) * | 2004-03-25 | 2005-11-01 | Bristol Myers Squibb Co | Coated tablet formulation and method |
| US7829720B2 (en) | 2004-05-04 | 2010-11-09 | Bristol-Myers Squibb Company | Process for preparing atazanavir bisulfate and novel forms |
| US20050256314A1 (en) * | 2004-05-04 | 2005-11-17 | Soojin Kim | Process employing controlled crystallization in forming crystals of a pharmaceutical |
| TWI415635B (zh) * | 2004-05-28 | 2013-11-21 | 必治妥施貴寶公司 | 加衣錠片調製物及製備彼之方法 |
| US7642049B2 (en) | 2006-06-30 | 2010-01-05 | Bristol-Myers Squibb Company | Method for identifying HIV-1 protease inhibitors with reduced metabolic affects through detection of human resistin polymorphisms |
| EP2116532B1 (en) * | 2007-06-12 | 2011-12-07 | Concert Pharmaceuticals, Inc. | Azapeptide derivatives as HIV protease inhibitors |
| MX2009013499A (es) * | 2007-06-22 | 2010-01-18 | Bristol Myers Squibb Co | Composiciones comprimidas que contienen atazanavir. |
| JP2010530892A (ja) * | 2007-06-22 | 2010-09-16 | ブリストル−マイヤーズ スクイブ カンパニー | アタザナビルを含む錠剤組成物 |
| DE602008005316D1 (de) * | 2007-06-22 | 2011-04-14 | Bristol Myers Squibb Co | Tablettierte atazanavirhaltige zusammensetzungen |
| CN101778624A (zh) * | 2007-06-22 | 2010-07-14 | 百时美施贵宝公司 | 含有阿扎那韦的压片组合物 |
| US8552036B2 (en) | 2009-01-12 | 2013-10-08 | Hetero Research Foundation | Polymorph of atazanavir sulfate |
| WO2011027324A1 (en) | 2009-09-03 | 2011-03-10 | Ranbaxy Laboratories Limited | Polymorphic forms of atazanavir sulfate |
| US9649311B2 (en) | 2009-10-26 | 2017-05-16 | Merck Sharp & Dohme Corp. | Solid pharmaceutical compositions containing an integrase inhibitor |
| EP2555757B1 (en) | 2010-04-09 | 2016-05-25 | Bristol-Myers Squibb Holdings Ireland | Atazanavir sulfate formulations with improved ph effect |
| EA201390464A1 (ru) | 2010-09-28 | 2013-08-30 | Рациофарм Гмбх | Способ сухой обработки атазанавира |
| US20140343290A1 (en) | 2011-07-27 | 2014-11-20 | Rakesh Kumar Singh | Process for the preparation of atazanavir or its bisulfate salt |
| US8461347B2 (en) | 2011-08-05 | 2013-06-11 | Scinopharm Taiwan, Ltd. | Process for preparing form A of atazanavir sulfate |
| WO2014030173A2 (en) * | 2012-08-24 | 2014-02-27 | Laurus Labs Private Limited | An improved process for the preparation of atazanavir bisulfate |
| WO2014036690A1 (zh) * | 2012-09-04 | 2014-03-13 | 上海迪赛诺化学制药有限公司 | 制备阿扎那韦硫酸氢盐a型结晶的方法 |
| CA2900705A1 (en) * | 2013-02-12 | 2014-08-21 | Cipla Limited | Process for preparing atazanavir sulphate |
| CN114763336A (zh) * | 2021-01-14 | 2022-07-19 | 威智医药有限公司 | 一种硫酸阿扎那韦晶型的生产方法 |
| CN115215792A (zh) * | 2022-06-27 | 2022-10-21 | 江西富祥药业股份有限公司 | 一种制备阿扎那韦或其硫酸盐的方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US658435A (en) * | 1900-03-22 | 1900-09-25 | William T Ginn | Coal-digger. |
| US4026897A (en) | 1974-01-31 | 1977-05-31 | Otsuka Pharmaceutical Company | 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives |
| US3980637A (en) | 1975-03-17 | 1976-09-14 | Bristol-Myers Company | Production of amoxicillin |
| DE3403329A1 (de) | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe |
| JPS6186211A (ja) | 1984-10-04 | 1986-05-01 | 日本碍子株式会社 | セラミックス複合構造体及びその製造法 |
| FR2623810B2 (fr) | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
| US5158777A (en) | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
| CA2068402C (en) | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
| US5428048A (en) | 1993-11-08 | 1995-06-27 | American Home Products Corporation | Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents |
| GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
| TW483763B (en) | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
| KR100486051B1 (ko) * | 1996-04-22 | 2005-09-09 | 노파르티스 아게 | 항바이러스활성헤테로시클릭아자헥산유도체 |
| US5849911A (en) | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
| GB9715896D0 (en) | 1997-07-28 | 1997-10-01 | Sca Packaging Ltd | Containers |
| US6087383A (en) * | 1998-01-20 | 2000-07-11 | Bristol-Myers Squibb Company | Bisulfate salt of HIV protease inhibitor |
| FR2779726B1 (fr) | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
| AU765128B2 (en) | 1999-03-22 | 2003-09-11 | Bristol-Myers Squibb Company | Fused pyridopyridazine inhibitors of cGMP phosphodiesterase |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| EP1243266A4 (en) | 1999-11-11 | 2007-03-07 | Kyorin Seiyaku Kk | SOLIDS PREPARATION FOR ORAL APPLICATION |
| EP1743655B1 (en) | 2000-01-21 | 2014-06-25 | Novartis AG | Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| US6254888B1 (en) | 2000-01-28 | 2001-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for coating pharmaceutical dosage forms |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| YU34501A (sh) | 2000-05-26 | 2003-10-31 | Pfizer Products Inc. | Postupak reaktivne kristalizacije radi povećanja veličine čestica |
| IL145106A0 (en) | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| US6670344B2 (en) | 2000-09-14 | 2003-12-30 | Bristol-Myers Squibb Company | Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts |
| US6867300B2 (en) | 2000-11-17 | 2005-03-15 | Bristol-Myers Squibb Company | Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| AU2002248792B2 (en) | 2001-04-18 | 2006-09-21 | Nostrum Pharmaceuticals Inc. | A novel coating for a sustained release pharmaceutical composition |
| AU2003201071A1 (en) | 2002-01-15 | 2003-07-30 | Ranbaxy Laboratories Limited | Stable pharmaceutical compositions comprising ace inhibitor(s) |
| KR100456833B1 (ko) | 2002-08-01 | 2004-11-10 | 주식회사 대웅 | 아목시실린 및 클라불라네이트를 함유하는 유핵정 |
| TW200534879A (en) | 2004-03-25 | 2005-11-01 | Bristol Myers Squibb Co | Coated tablet formulation and method |
| US7829720B2 (en) | 2004-05-04 | 2010-11-09 | Bristol-Myers Squibb Company | Process for preparing atazanavir bisulfate and novel forms |
| US20050256314A1 (en) | 2004-05-04 | 2005-11-17 | Soojin Kim | Process employing controlled crystallization in forming crystals of a pharmaceutical |
| US20050288343A1 (en) | 2004-05-19 | 2005-12-29 | Andrew Rusowicz | Process of preparing substituted carbamates and intermediates thereof |
| TWI415635B (zh) | 2004-05-28 | 2013-11-21 | 必治妥施貴寶公司 | 加衣錠片調製物及製備彼之方法 |
-
2005
- 2005-05-02 US US11/119,558 patent/US7829720B2/en active Active
- 2005-05-03 PL PL05744537T patent/PL1755596T3/pl unknown
- 2005-05-03 JP JP2007511502A patent/JP5086069B2/ja not_active Expired - Lifetime
- 2005-05-03 BR BRPI0509595A patent/BRPI0509595B8/pt not_active IP Right Cessation
- 2005-05-03 EP EP05744537.1A patent/EP1755596B9/en not_active Expired - Lifetime
- 2005-05-03 CA CA2777216A patent/CA2777216A1/en not_active Abandoned
- 2005-05-03 EP EP15180557.9A patent/EP2980074A1/en not_active Ceased
- 2005-05-03 RS RS20150653A patent/RS54284B1/sr unknown
- 2005-05-03 HU HUE05744537A patent/HUE026242T2/en unknown
- 2005-05-03 PT PT57445371T patent/PT1755596E/pt unknown
- 2005-05-03 DK DK05744537.1T patent/DK1755596T5/en active
- 2005-05-03 ES ES05744537.1T patent/ES2552219T3/es not_active Expired - Lifetime
- 2005-05-03 CA CA2565629A patent/CA2565629C/en not_active Expired - Lifetime
- 2005-05-03 HR HRP20150962TT patent/HRP20150962T2/hr unknown
- 2005-05-03 EP EP20130175944 patent/EP2669273A1/en not_active Withdrawn
- 2005-05-03 AU AU2005240622A patent/AU2005240622B2/en not_active Expired
- 2005-05-03 MX MXPA06012612A patent/MXPA06012612A/es active IP Right Grant
- 2005-05-03 WO PCT/US2005/015333 patent/WO2005108349A2/en not_active Ceased
- 2005-05-03 SI SI200532001T patent/SI1755596T1/sl unknown
- 2005-05-03 KR KR1020067025370A patent/KR101153606B1/ko not_active Expired - Lifetime
-
2006
- 2006-10-31 IL IL178965A patent/IL178965A/en active IP Right Grant
- 2006-11-27 NO NO20065441A patent/NO341013B1/no unknown
-
2009
- 2009-01-27 US US12/360,468 patent/US7838678B2/en not_active Expired - Lifetime
-
2010
- 2010-04-16 AU AU2010201538A patent/AU2010201538B2/en not_active Expired
- 2010-10-08 US US12/900,588 patent/US8513428B2/en active Active
-
2015
- 2015-11-10 CY CY20151101005T patent/CY1116919T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007536245A5 (https=) | ||
| HRP20150962T2 (hr) | Postupak za pripremu atazanavir bisulfata i novih oblika | |
| JPH0631300B2 (ja) | 結晶性アジスロマイシン２水和物及びその製法 | |
| WO2008144980A1 (fr) | Procédé de préparation et intermédiaires de la capécitabine | |
| JP2021536497A (ja) | アマンタジン系硝酸エステル誘導体の製造プロセス | |
| RU2417217C2 (ru) | Устойчивые и стабильные при хранении солевые кластеры соли аммония и минеральной соли с анионами двухосновных кислот и способ их получения | |
| KR20080064990A (ko) | 세프디니르의 제조방법 | |
| SK50052004A3 (sk) | Nová forma N-(trans-4-izopropylcyklohexylkarbonyl)-D-fenylalanínu | |
| CN108017561A (zh) | 一种精制卡谷氨酸的方法 | |
| CN116396226A (zh) | 一种替戈拉生及其中间体化合物的制备方法 | |
| JPS6026112B2 (ja) | ２−フエニルアミノ−イミダゾリン−（２）化合物 | |
| CN105037216A (zh) | 一种月桂酰精氨酸盐酸盐的制备方法 | |
| JPWO2003087039A1 (ja) | 新規ナテグリニド結晶 | |
| CN102070654B (zh) | 一种头孢硫脒的制备方法 | |
| CN109810009B (zh) | 一种改进的合成l-甲状腺素钠的方法 | |
| JP2012524044A (ja) | ２，４，６−オクタトリエン−１−酸及び２，４，６−オクタトリエン−１−オールの調製方法 | |
| CN100361995C (zh) | 注射级无菌头孢噻肟钠的一步法制备工艺 | |
| CN103254268A (zh) | 一种制备度他雄胺的工艺 | |
| KR101557702B1 (ko) | 미티글리니드 칼슘 이수화물의 제조방법 | |
| CN103724248B (zh) | 维格列汀工艺杂质的制备方法 | |
| CN105384614B (zh) | 一种原乙酸三甲酯的合成方法 | |
| KR101469015B1 (ko) | 몬테루카스트의 제조방법 및 이에 사용되는 중간체 | |
| CN115403560B (zh) | 一种艾普拉唑镁晶型及其制备方法 | |
| CN101575286A (zh) | 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法 | |
| CN105237431B (zh) | 一种非那西汀的制备与结晶方法 |